Level C· Early human research exploring benefitsProspective StudyPubMed

In vitro proliferation and differentiation of adipose-derived stem cells isolated using anti-CD105 magnetic beads.

Lv XJ., Zhou GD., Liu Y., Liu X., Chen JN., Luo XS.

Prospective Study on Face & Skin, published in Int J Mol Med (2012) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Int J Mol Med (2012)
Country
Greece
Reported sample size
—
Source database
PubMed
PMID
22825748
DOI
10.3892/ijmm.2012.1063
Citations
23

Abstract (original English)

The present study aimed to investigate the feasibility of isolating adipose-derived stem cells (ADSCs) by selecting cells that express the surface receptor CD105. Surface antigen expression of the unsorted cells was undertaken using FACS analysis. Primary adipose-derived cells were isolated. The second passage cells were incubated with anti-CD105 magnetic beads, and separated using a magnetic separator. Cell growth and colony formation was determined by counting and Giemsa staining, respectively. Cells also underwent histological immunohistochemical, and RT-PCR analyses to determine their chondrogenic, adipogenic and osteogenic potential. Increased cell proliferation and colony formation was observed in CD105-positive (CD105⁺) as compared to the CD105-negative (CD105⁻) cells (P<0.001). Following induction, the expression of type II collagen and the number of calcium deposits and lipid droplets in the CD105⁺ ADCs were markedly higher than in the CD105⁻ ADCs. Furthermore, increased alkaline phosphatase (AKP), leptin and PPARγ2 mRNA expression was detected in the CD105⁺ ADCs (P<0.01). Isolation of CD105⁺ ADSCs by MACS was feasible. Thus, CD105 can be used as a relatively specific marker for the selection of ADSCs. Although the chondrogenic, adipogenic and osteogenic potential of these cells is suggestive of their potential for use in tissue engineering treatments, further in vivo

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAdultAntibodiesAntigens, CDCell DifferentiationCell ProliferationCells, CulturedEndoglinFemaleHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research